Related Experiment Video
Updated: Dec 10, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
The Role of the JC Virus in Central Nervous System Tumorigenesis
Nicholas Ahye1, Anna Bellizzi1, Dana May1
1Center for Neurovirology, Department of Neuroscience, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.
Abstract:
Cancer is the second leading cause of mortality worldwide. The study of DNA tumor-inducing viruses and their oncoproteins as a causative agent in cancer initiation and tumor progression has greatly enhanced our understanding of cancer cell biology. The initiation of oncogenesis is a complex process. Specific gene mutations cause functional changes in the cell that ultimately result in the inability to regulate cell differentiation and proliferation effectively. The human neurotropic Polyomavirus JC (JCV) belongs to the family Polyomaviridae and it is the causative agent of progressive multifocal leukoencephalopathy (PML), which is a fatal neurodegenerative disease in an immunosuppressed state. Sero-epidemiological studies have indicated JCV infection is prevalent in the population (85%) and that initial infection usually occurs during childhood. The JC virus has small circular, double-stranded DNA that includes coding sequences for viral early and late proteins. Persistence of the virus in the brain and other tissues, as well as its potential to transform cells, has made it a subject of study for its role in brain tumor development. Earlier observation of malignant astrocytes and oligodendrocytes in PML, as well as glioblastoma formation in non-human primates inoculated with JCV, led to the hypothesis that JCV plays a role in central nervous system (CNS) tumorigenesis. Some studies have reported the presence of both JC viral DNA and its proteins in several primary brain tumor specimens. The discovery of new Polyomaviruses such as the Merkel cell Polyomavirus, which is associated with Merkel cell carcinomas in humans, ignited our interest in the role of the JC virus in CNS tumors. The current evidence known about JCV and its effects, which are sufficient to produce tumors in animal models, suggest it can be a causative factor in central nervous system tumorigenesis. However, there is no clear association between JCV presence in CNS and its ability to initiate CNS cancer and tumor formation in humans. In this review, we will discuss the correlation between JCV and tumorigenesis of CNS in animal models, and we will give an overview of the current evidence for the JC virus's role in brain tumor formation.
Insights
The JC virus (JCV) is linked to central nervous system (CNS) tumors in animal models. While prevalent in humans, its direct role in human CNS cancer initiation remains unclear.
Area of Science:
- Neuroscience
- Oncology
- Virology
Background:
- Cancer is a leading global cause of death, with DNA tumor viruses playing a role in oncogenesis.
- The human neurotropic Polyomavirus JC (JCV), prevalent in 85% of the population, causes progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals.
- JCV's persistence and cell-transforming potential make it a focus for brain tumor research.
Purpose of the Study:
- To review the correlation between JCV and central nervous system (CNS) tumorigenesis in animal models.
- To provide an overview of current evidence regarding JCV's role in human brain tumor formation.
- To explore the hypothesis that JCV may contribute to CNS tumorigenesis.
Main Methods:
- Review of existing scientific literature and studies.
- Analysis of observations in progressive multifocal leukoencephalopathy (PML) cases.
- Examination of findings from non-human primate studies inoculated with JCV.
Main Results:
- JCV has been detected in some primary human brain tumor specimens.
- JCV can induce tumors in animal models, suggesting a potential causative role in CNS tumorigenesis.
- Malignant astrocytes and oligodendrocytes observed in PML, alongside glioblastoma in primates, support the JCV-CNS tumor hypothesis.
Conclusions:
- Current evidence suggests JCV can be a causative factor in CNS tumorigenesis, particularly based on animal model data.
- A definitive association between JCV presence in the human CNS and the initiation of CNS cancer is not yet established.
- Further research is needed to clarify JCV's precise role in human brain tumor development.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...